Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$573,779,209
+$91,759,386 QoQ
Shares Held
2,280,159
+2.9% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#74
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $4,791,103,609 across 11 Drug Manufacturers - General names. ABBV ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,277,161 | $1,531,865,340 | |
| 2 | JNJ |
Johnson & Johnson
|
3,563,268 | $904,963,170 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
12,226,954 | $704,517,086 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,280,159 | $573,779,209 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,455,664 | $315,552,823 | |
| 6 | PFE |
Pfizer Inc
|
12,896,296 | $310,542,805 | |
| 7 | AMGN |
Amgen Inc
|
613,694 | $222,230,868 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,705,761 | $215,505,842 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $573,779,209 | 2,280,159 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $482,019,823 | 2,216,285 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $731,937,091 | 3,203,366 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $650,242,345 | 2,808,337 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $476,054,227 | 2,564,671 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $574,386,713 | 2,741,441 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $431,118,855 | 2,426,105 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $525,660,948 | 2,661,844 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $359,043,671 | 2,093,305 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $339,756,896 | 1,865,771 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $293,440,496 | 1,893,531 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $273,165,713 | 1,832,589 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $198,071,958 | 1,470,140 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $227,661,955 | 1,428,512 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $248,814,593 | 1,539,599 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $254,686,960 | 1,897,675 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $308,515,546 | 2,014,335 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $289,644,690 | 1,786,717 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $310,155,904 | 2,290,664 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $215,865,775 | 2,001,166 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $201,680,678 | 1,790,489 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $197,623,029 | 1,826,123 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $184,528,477 | 1,722,151 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $169,911,985 | 1,939,856 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $197,325,697 | 2,009,836 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $174,779,552 | 2,293,996 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||